FBXO5 Antikörper (N-Term)
Kurzübersicht für FBXO5 Antikörper (N-Term) (ABIN3024714)
Target
Alle FBXO5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- EMI-1 Antibody (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A human partial recombinant N-terminal protein fragment was used as the immunogen for the EMI-1 antibody.
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
-
Optimal dilution of the EMI-1 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the EMI-1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- FBXO5 (F-Box Protein 5 (FBXO5))
-
Andere Bezeichnung
- EMI-1
-
Hintergrund
- Early Mitotic Inhibitor-1 regulates mitosis by inhibiting the anaphase promoting complex/cyclosome (APC). It is a conserved F box protein containing a zinc-binding region essential for APC inhibition. The protein functions to promote cyclin A accumulation and S phase entry in somatic cells by inhibiting the APC complex. At the G1-S transition, EMI-1 is transcriptionally induced by the E2F transcription factor. Overexpression accelerates S-phase entry and can override a G1 block caused by overexpression of Cdh1 or the E2F-inhibitor p105 retinoblastoma protein (pRb). Depleting cells of EMI-1 through RNA interference prevents accumulation of cyclin A and inhibits S phase entry.
-
UniProt
- Q9UKT4
-
Pathways
- Mitotic G1-G1/S Phases
Target
-